Sorafenib impurity INT-1-D

Sorafenib impurity INT-1-D Struktur
1446410-29-2
CAS-Nr.
1446410-29-2
Englisch Name:
Sorafenib impurity INT-1-D
Synonyma:
Sorafenib impurity INT-1-D;6-chloro-N-methyl-4-(methylamino)picolinamide;2-Pyridinecarboxamide, 4-chloro-N-methyl-6-(methylamino)-
CBNumber:
CB96225118
Summenformel:
C8H10ClN3O
Molgewicht:
199.64
MOL-Datei:
1446410-29-2.mol

Sorafenib impurity INT-1-D Eigenschaften

Siedepunkt:
347.5±42.0 °C(Predicted)
Dichte
1.292±0.06 g/cm3(Predicted)
pka
13.26±0.46(Predicted)

Sicherheit

Sorafenib impurity INT-1-D Chemische Eigenschaften,Einsatz,Produktion Methoden

Sorafenib impurity INT-1-D Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Sorafenib impurity INT-1-D Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11922 58
QUALITY CONTROL SOLUTIONS LTD.
+86-0755-66853366 +86-13670046396
export03@qcsrm.com China 24342 58
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5158 50
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9906 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 10000 55
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD 0755-0755-83725350 13380397412
3001280422@qq.com China 10001 58
Molcoo Chemicals Inc. 18576690171
3001025734@qq.com China 8880 58
Shanghai YuZn Pharm. Technology Co.,Ltd. 15921286451; 15921286451
2010681527@qq.com China 5183 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
3641133981@qq.com China 9713 58
Hubei Moco Chemical Co., Ltd. 18627753421; 18627756402
3001051413@qq.com China 20319 58

  • Sorafenib impurity INT-1-D
  • 2-Pyridinecarboxamide, 4-chloro-N-methyl-6-(methylamino)-
  • 6-chloro-N-methyl-4-(methylamino)picolinamide
  • 1446410-29-2
Copyright 2019 © ChemicalBook. All rights reserved